Keeps BioPharma Inc (256940)

Currency in KRW
10,340
-100(-0.96%)
Closed·
256940 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10,00010,500
52 wk Range
6,38022,150
Key Statistics
Bid/Ask
10,340.00 / 10,350.00
Prev. Close
10,440
Open
10,400
Day's Range
10,000-10,500
52 wk Range
6,380-22,150
Volume
171.78K
Average Volume (3m)
151.76K
1-Year Change
53.4125%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
256940 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13,000
Upside
+25.73%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Keeps BioPharma Inc Company Profile

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing. The company was formerly known as KPS Corporation and changed its name to Keeps Biopharma Inc. in April 2025. Keeps Biopharma Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Compare 256940 to Peers and Sector

Metrics to compare
256940
Peers
Sector
Relationship
P/E Ratio
−7,324.0x−5.5x12.4x
PEG Ratio
72.950.130.01
Price/Book
2.7x1.1x2.4x
Price / LTM Sales
1.3x0.9x2.4x
Upside (Analyst Target)
25.7%24.0%19.6%
Fair Value Upside
Unlock9.5%3.2%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 13,000
(+25.73% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
-22.00 / --
Revenue / Forecast
40.93B / 66.10B
EPS Revisions
Last 90 days

256940 Income Statement

People Also Watch

120,800
007660
-1.15%
436,500
128940
0.00%
105,300
095340
-0.19%
92,400
058610
-4.64%
36,850
008930
0.00%

FAQ

What Is the Keeps BioPharma (256940) Stock Price Today?

The Keeps BioPharma stock price today is 10,340

What Stock Exchange Does Keeps BioPharma Trade On?

Keeps BioPharma is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Keeps BioPharma?

The stock symbol for Keeps BioPharma is "256940."

What Is the Keeps BioPharma Market Cap?

As of today, Keeps BioPharma market cap is 207.61B.

What Is Keeps BioPharma's Earnings Per Share (TTM)?

The Keeps BioPharma EPS (TTM) is -1.47.

When Is the Next Keeps BioPharma Earnings Date?

Keeps BioPharma will release its next earnings report on Mar 19, 2026.

From a Technical Analysis Perspective, Is 256940 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Keeps BioPharma Stock Split?

Keeps BioPharma has split 1 times.

How Many Employees Does Keeps BioPharma Have?

Keeps BioPharma has 109 employees.

What is the current trading status of Keeps BioPharma (256940)?

As of Jan 18, 2026, Keeps BioPharma (256940) is trading at a price of 10,340, with a previous close of 10,440. The stock has fluctuated within a day range of 10,000 to 10,500, while its 52-week range spans from 6,380 to 22,150.

What Is Keeps BioPharma (256940) Price Target According to Analysts?

The average 12-month price target for Keeps BioPharma is KRW13000, with a high estimate of KRW13000 and a low estimate of KRW13000. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +25.73% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.